In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicity

Environmental Toxicology and Pharmacology

Volumn 27, Issue 1, 2009, Pages 103-110

  Zhang, Peng ^a   Xu, Yongping ^a   Li, Like ^a   Jiang, Qi ^a   Wang, Manji ^b   Jin, Liji ^a  

^a DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Methylmercury; Neuroprotection; Oxidative stress; Pyrroloquinoline quinone

Indexed keywords

CASPASE 3; GLUTATHIONE; METHYLMERCURY; PROTEIN BCL 2; PYRROLOQUINOLINE QUINONE; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION;

ANIMALIA;

EID: 57149134372     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2008.08.010     Document Type: Article

References (48)

1. Bauerly K.A., Storms D.H., Harris C.B., Hajizadeh S., Sun M.Y., Cheung C.P., Satre M.A., Fascetti A.J., Tchaparian E., and Rucker R.B. Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and rat. Biochim. Biophys. Acta 1760 (2006) 1741-1748
2. Budihardjo I., Oliver H., Lutter M., Luo X., and Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15 (1999) 269-290
3. Castoldi A.F., Barni S., Turin I., Gandini C., and Manzo L. Early acute necrosis, delayed apoptosis and cytoskeletal breakdown in cultured cerebellar granule neurons exposed to methylmercury. J. Neurosci. Res. 59 (2000) 775-787
4. Cernichiari E., Brewer R., Myers G.J., Marsh D.O., Lapham L.W., Cox C., Shamlaye C.F., Berlin M., Davidson P.W., and Clarkson T.W. Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology 16 (1995) 705-710
5. Choi B.H., Yee S., and Robles M. The effects of glutathione glycoside in methylmercury poisoning. Toxicol. Appl. Pharmacol. 141 (1996) 357-364
6. Clarkson T.W. The toxicology of mercury. Crit. Rev. Clin. Lab. Sci. 34 (1997) 369-403
7. Gallop P.M., Paz M.A., Fluckiger R., Stang P.J., Zhdankin V.V., and Tykwinski R.R. Highly effective PQQ inhibition by alkynyl and aryl mono- and diiodonium salts. J. Am. Chem. Soc. 115 (1993) 11702-11704
8. 2+ pathway blockers differentially protect against methylmercury and mercuric chloride neurotoxicity. J. Neurosci. Res. 66 (2001) 135-145
9. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Nati. Acad. Sci. USA 73 (1976) 2424-2428
10. Hamagishi Y., Murata S., Kamei H., Oki T., Adachi O., and Ameyama M. New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J. Pharmacol. Exp. Ther. 255 (1990) 980-985
11. Hara H., Hiramatsu H., and Adachi T. Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem. Res. 32 (2007) 489-495
12. Harada M. Minamata disease: methylmercury poisoning in japan caused by environmental pollution. Crit. Rev. Toxicol. 25 (1995) 1-24
13. He K., Nukada H., Urakami T., and Michael P.M. Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem. Pharmacol. 65 (2003) 67-74
14. Hiraku Y., and Kawanishi S. NADH-mediated DNA damage induced by a new coenzyme, pyrroloquinoline quinone, in the presence of copper(II) ion. FEBS Lett. 393 (1996) 317-320
15. Igata A. Epidemiological and clinical features of minamata disease. Environ. Res. 63 (1993) 157-169
16. Kasahara T., and Kato T. Nutritional biochemistry: a new redox cofactor vitamin for mammals. Nature 422 (2003) 832
17. Koh J.Y., and Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20 (1987) 83-90
18. Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80 (1992) 879-886
19. Kumazawa T., Seno H., Urakami T., Matsumoto T., and Suzuki O. Trace levels of pyrroloquinoline quinone in human and rat samples deteceted by gas chromatoraphy/mass spectrometry. Biochim. Biophys. Acta 1156 (1992) 62-66
20. Kumazawa T., Sato K., Seno H., Ishii A., and Suzuki O. Levels of pyrroloquinoline quinone in various foods. Biochem. J. 307 (1995) 331-333
21. Kunimoto M. Methylmercury induces apoptosis of rat cerebellar neurons in primary culture. Biochem. Biophys. Res. Commun. 204 (1994) 310-317
22. Lapham L.W., Cernichiari E., Cox C., Myers G.J., Baggs R.B., Brewer R., Shamlaye C.F., Davidson P.W., and Clarkson T.W. An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology 16 (1995) 689-704
23. Liu X., and Zhu X.Z. Roles of p53, c-Myc, Bcl-2, Bax, and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor. Mol. Brain Res. 70 (1999) 210-216
24. Miura K., Koide N., Himeno S., Nakagawa I., and Imura N. The involvement of microtubular disruption in methylmercury-induced apoptosis in neuronal and nonneuronal cell lines. Toxicol. Appl. Pharmacol. 160 (1999) 279-288
25. Nicholls D.G., and Budd S.L. Mitochondria and neuronal survival. Physiol. Rev. 80 (2000) 315-360
26. Nishigori H., Yasunaga M., Mizumura M., Lee J.W., and Iwatsuru M. Preventive effects of pyrroloquinoline quinone on formation of cataract and decline of lenticular and hepatic glutathione of developing chick embryo after glucocorticoid treatment. Life Sci. 45 (1989) 593-598
27. Park S.T., Lim K.T., Chung Y.T., and Kim S.U. Methylmercury-induced neurotoxicity in cerebral neuron culture is blocked by antioxidants and NMDA receptor antagonists. Neurotoxicology 17 (1996) 37-46
28. Salisbury S.A., Forrest H.S., Cruse W.B., and Kennard O. A novel coenzyme from bacterial primary alcohol dehydrogenases. Nature 280 (1979) 843-844
29. Sanfeliu C., Sebastia J., and Kim S.U. Methylmercury neurotoxicity in cultures of human neurons, astrocytes, neuroblastoma cells. Neurotoxicology 22 (2001) 317-327
30. Sanfeliu C., Sebastia J., Cristofol R., and Rodriguez-Farre E. Neurotoxicity of organomercurial compounds. Neurotox. Res. 5 (2003) 283-306
31. Sarafian T.A. Methylmercury-induced generation of free radicals: biological implications. Metal Ions Biol. Syst. 36 (1999) 415-444
32. Satoh T., Enokido Y., Aoshima H., Uchiyama Y., and Hatanaka H. Changes in mitochondrial membrane potential during oxidative stress induced apoptosis in PC12 cells. J. Neurosci. Res. 50 (1997) 413-420
33. Shenker B.J., Guo T.L., Ou I., and Shapiro I.M. Induction of apoptosis in human T-cells by methylmercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. Toxicol. Appl. Pharmacol. 157 (1999) 23-35
34. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., and Tsujimoto Y. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene 13 (1996) 21-29
35. 14C] pyrroloquinoline quinone in mice. Proc. Soc. Exp. Biol. Med. 197 (1991) 27-31
36. Solange D., and Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10 (2000) 369-377
37. Sone N., Larsstuvold M.K., and Kagawa Y. Effect of methylmercury on phosphorylation, transport, and oxidation in mammalian mitochondria. J. Biochem. 82 (1977) 859-868
38. Steinberg F.M., Gershwin E., and Rucker R.B. Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J. Nutr. 124 (1994) 744-753
39. Stites T., Storms D., Bauerly K., Mah J., Harris C., Fascetti A., Rogers Q., Tchaparian E., Satre M., and Rucker R.B. Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J. Nutr. 136 (2006) 390-396
40. Swamy S.M., and Huat B.T. Intracellular glutathione depletion and reactive oxygen species generation are important in alpha-hederin induced apoptosis of P388 cells. Mol. Cell Biochem. 245 (2003) 127-139
41. Takahashi A., Masuda A., Sun M., Centonze V.E., and Herman B. Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2 dependent alterations in mitochondrial pH (pHm). Brain Res. Bull. 62 (2004) 497-504
42. Urakami T., Yoshida C., Akaike T., Maeda H., Nishigori H., and Niki E. Synthesis of monoesters of pyrroloquinoline quinone and imidazo-pyrroloquinoline, and radical scavenging activities using electron spinresonance in vitro and pharmacological activity in vivo. J. Nutr. Sci. Vitaminol. (Tokyo) 43 (1997) 19-33
43. Vian L., Vincent J., Maurin J., Fabre I., Giroux J., and Cano J.P. Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation. Toxicol. In Vitro 9 (1995) 185-190
44. Wang H., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27 (1999) 612-616
45. Watanabe A., Hobara N., Ohsawa T., Higashi T., and Tsuji T. Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J. Med. Sci. 38 (1989) 49-51
46. Xu F., Mack C.P., Quandt K.S., Shlafer M., Massey V., and Hultquist D.E. Pyrroloquinoline quinone acts with flavin reductase to reduce ferryl myoglobin in vitro and protects isolated heart from re-oxygenation injury. Biochem. Biophys. Res. Commun. 193 (1993) 434-439
47. Yee S., and Choi B.H. Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology 17 (1996) 17-26
48. Yoshino Y., Mozai T., and Nakao K. Distribution of mercury in the brain and its subcellular units in experimental organic mercury poisoning. J. Neurochem. 13 (1966) 397-406